Stem Cells: The Revolutionary Cure
Innovators in Stem Cell Research
The UC Davis Stem Cell program has brought together physicians, research scientists, biomedical engineers, and experts to establish the UC Davis Institute for Regenerative Cures, an institute devoted to advancing stem cell therapies to cure patients and families suffering from chronic disease or injury. UC Davis houses a Good Manufacturing Practice facility, which has multiple manufacturing rooms utilized for stem cell research and human clinical trials. With 150 faculty members conducting stem cell research, many current UC Davis studies aim to find which types of stem cells can most effectively deal with a variety of diseases/ problems such as bladder disease, hearing loss, HIV, Alzheimer's, tumors, etc.
(Image 12, text 7)
​
CIRM's mission is to accelerate "stem cell treatments to patients with unmet medical needs." To accomplish this mission, CIRM funds thousands of dollars to a variety of institutions researching all areas of stem cell research. Working closely with other state and federal agencies, CIRM ensures that all funded stem cell research shows the potential to accelerate treatment to patients in need. CIRM-funded institutions include Stanford University, UCLA, and UCSD among many others.
(Image 13, text 8,9)
The National Institutes of Health, part of the U.S Department of Health and Human Services, have been making important discoveries that improve health and save lives since 1887 as the nation's medical research agency. Investing approximately $32.3 billion annually in medical research, the NIH seeks to foster creative discoveries, develop the resources to prevent disease, expand medical knowledge, and promote the highest level of scientific integrity. The Regenerative Medicine Program is only one of the 27 Institutes within the NIH. The RMP serve as a national resource for the development of new stem cell medical applications and cell-based therapies. The RMP's Dr. Kapil Bharti at the National Eye Institute, for example, seeks to treat age-related macular degeneration with stem cell therapy.
(Image 14, text 10,11)
​